FDA-Drug2026-07-29Class IIMISBRANDING

Major Pharmaceuticals levothyroxine sodium tablets recalled for subpotent drug

LABEL MIX UPNationwide distribution

Major Pharmaceuticals levothyroxine tablets recalled for reduced potency

Major Pharmaceuticals is recalling levothyroxine sodium 50 mcg tablets (lot N02200, expiration 10/2026) because they do not contain the full labeled dose. Levothyroxine is a thyroid hormone replacement medication, and a subpotent tablet may not provide the intended therapeutic effect for patients who depend on consistent dosing.

  • Check if you have levothyroxine sodium 50 mcg tablets from Major Pharmaceuticals with lot number N02200.
  • Do not stop taking your levothyroxine without speaking to your doctor.
  • Contact your pharmacist or doctor to confirm whether your supply is affected and discuss next steps.
Hazard

Subpotent Drug

Sold states
Nationwide in the USA.
Affected count
N/A
Manufactured in
7000 Cardinal Pl, N/A, Dublin, OH, United States
Products
Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6950-61

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0701-2026

More Major Pharmaceuticals recalls

Don't want to check this manually?

We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Get the Sunday Brief